Keller ET - Search Results

1

The effect of osteoprotegerin administration on the intra-tibial growth of the osteoblastic LuCaP 23.1 prostate cancer xenograft.

Kiefer JA, Vessella RL, Quinn JE, Odman AM, Zhang J, Keller ET, Kostenuik PJ, Dunstan CR, Corey E. Kiefer JA, et al. Among authors: keller et. Clin Exp Metastasis. 2004;21(5):381-7. doi: 10.1007/s10585-004-2869-0. Clin Exp Metastasis. 2004. PMID: 15672862 Free article.

2

Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro.

Lin DL, Tarnowski CP, Zhang J, Dai J, Rohn E, Patel AH, Morris MD, Keller ET. Lin DL, et al. Among authors: keller et. Prostate. 2001 May 15;47(3):212-21. doi: 10.1002/pros.1065. Prostate. 2001. PMID: 11351351 Free article.

3

Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone.

Zhang J, Dai J, Qi Y, Lin DL, Smith P, Strayhorn C, Mizokami A, Fu Z, Westman J, Keller ET. Zhang J, et al. Among authors: keller et. J Clin Invest. 2001 May;107(10):1235-44. doi: 10.1172/JCI11685. J Clin Invest. 2001. PMID: 11375413 Free PMC article.

4

Prostate carcinoma skeletal metastases: cross-talk between tumor and bone.

Keller ET, Zhang J, Cooper CR, Smith PC, McCauley LK, Pienta KJ, Taichman RS. Keller ET, et al. Cancer Metastasis Rev. 2001;20(3-4):333-49. doi: 10.1023/a:1015599831232. Cancer Metastasis Rev. 2001. PMID: 12085970 Free article. Review.

5

Osteoprotegerin abrogates chronic alcohol ingestion-induced bone loss in mice.

Zhang J, Dai J, Lin DL, Habib P, Smith P, Murtha J, Fu Z, Yao Z, Qi Y, Keller ET. Zhang J, et al. Among authors: keller et. J Bone Miner Res. 2002 Jul;17(7):1256-63. doi: 10.1359/jbmr.2002.17.7.1256. J Bone Miner Res. 2002. PMID: 12096839 Free article.

6

Characterization of C4-2 prostate cancer bone metastases and their response to castration.

Pfitzenmaier J, Quinn JE, Odman AM, Zhang J, Keller ET, Vessella RL, Corey E. Pfitzenmaier J, et al. Among authors: keller et. J Bone Miner Res. 2003 Oct;18(10):1882-8. doi: 10.1359/jbmr.2003.18.10.1882. J Bone Miner Res. 2003. PMID: 14584899 Free article.

7

Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone.

Zhang J, Dai J, Yao Z, Lu Y, Dougall W, Keller ET. Zhang J, et al. Among authors: keller et. Cancer Res. 2003 Nov 15;63(22):7883-90. Cancer Res. 2003. PMID: 14633717

8

In vivo visualization of aging-associated gene transcription: evidence for free radical theory of aging.

Zhang J, Dai J, Lu Y, Yao Z, O'Brien CA, Murtha JM, Qi W, Hall DE, Manolagas SC, Ershler WB, Keller ET. Zhang J, et al. Among authors: keller et. Exp Gerontol. 2004 Feb;39(2):239-47. doi: 10.1016/j.exger.2003.10.024. Exp Gerontol. 2004. PMID: 15036418

9

Opg, RANKl, and RANK in cancer metastasis: expression and regulation.

Brown JM, Zhang J, Keller ET. Brown JM, et al. Among authors: keller et. Cancer Treat Res. 2004;118:149-72. doi: 10.1007/978-1-4419-9129-4_7. Cancer Treat Res. 2004. PMID: 15043192 Review. No abstract available.

10

In vivo real-time imaging of TGF-beta-induced transcriptional activation of the RANK ligand gene promoter in intraosseous prostate cancer.

Zhang J, Lu Y, Dai J, Yao Z, Kitazawa R, Kitazawa S, Zhao X, Hall DE, Pienta KJ, Keller ET. Zhang J, et al. Among authors: keller et. Prostate. 2004 Jun 1;59(4):360-9. doi: 10.1002/pros.20019. Prostate. 2004. PMID: 15065084 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters